Search Results - "Rajiwate, Z."

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    1460P GALLANT-1: GB1211 galectin-3 (Gal-3) inhibitor plus atezolizumab (atz) for first line treatment in patients (pts) with advanced/metastatic non-small cell lung cancer (NSCLC)

    1460P GALLANT-1: GB1211 galectin-3 (Gal-3) inhibitor plus atezolizumab (atz) for first line treatment in patients (pts) with advanced/metastatic non-small cell lung cancer (NSCLC) by Aparisi Aparisi, F.D.A., Felip, E., Pichon, E., Carcereny, E., Barre, P., Raumlau, R., Sethi, T., Lindmark, B., Slack, R., MacKinnon, A., Aslanis, V., Phung, D., Jensen, P., Rajiwate, Z., Ross, G., Basse, L., Ghiringhelli, F.

    Published in Annals of oncology (01-10-2023)
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    1192TiP GALLANT-1: Galectin-3 (Gal-3) inhibitor, GB1211, plus atezolizumab (atz) in patients (pts) with non-small cell lung cancer (NSCLC) - a dose finding study followed by a randomised, double-blind, placebo-controlled trial

    1192TiP GALLANT-1: Galectin-3 (Gal-3) inhibitor, GB1211, plus atezolizumab (atz) in patients (pts) with non-small cell lung cancer (NSCLC) - a dose finding study followed by a randomised, double-blind, placebo-controlled trial by Ghiringhelli, F., Barre, P., Pichon, E., Ponce Aix, S., Juan Vidal, O.J., Carcereny Costa, E., Sethi, T., Lindmark, B., MacKinnon, A., Aslanis, V., Phung, D.H., Jensen, P., Rajiwate, Z., Ross, G., Basse, L.

    Published in Annals of oncology (01-09-2022)
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: